Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 50:1948-1955, doi:10.1016/j.jacc.2007.06.052 (Published online 29 October 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.06.052v1
50/20/1948    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeller, M.
Right arrow Articles by Lagrost, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zeller, M.
Right arrow Articles by Lagrost, L.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: ATHEROSCLEROSIS

High Serum Cholesteryl Ester Transfer Rates and Small High-Density Lipoproteins Are Associated With Young Age in Patients With Acute Myocardial Infarction

Marianne Zeller, PhD*, David Masson, PharmD, PhD{dagger},||, Michel Farnier, MD, PhD{ddagger}, Luc Lorgis, MD§, Valérie Deckert, PhD{dagger}, Jean-Paul Pais de Barros, PhD{dagger}, Catherine Desrumaux, PhD{dagger}, Pierre Sicard, MSc*, Jacques Grober, PhD{dagger}, Denis Blache, PhD{dagger}, Philippe Gambert, MD, PhD{dagger},||, Luc Rochette, PharmD, PhD*, Yves Cottin, MD, PhD§ and Laurent Lagrost, PhD{dagger},*

* Laboratory of Cardiovascular and Experimental Physiopathology and Pharmacology, IFR Santé STIC, Dijon, France
{dagger} INSERM U866, University of Burgundy, Dijon, France
{ddagger} Point Médical, Dijon, France
§ Department of Cardiology, University Hospital, Dijon, France
|| Department of Medical Biochemistry, University Hospital, Dijon, France.

Manuscript received January 12, 2007; revised manuscript received June 8, 2007, accepted June 11, 2007.

* Reprint requests and correspondence: Dr. Laurent Lagrost, INSERM U866, Medical School, 7 bld Jeanne d’Arc, 21079 Dijon Cedex, France. (Email: laurent.lagrost{at}u-bourgogne.fr).

Objectives: Our aim was to characterize cholesteryl ester transfer protein (CETP) activity in the early phase of acute myocardial infarction (MI).

Background: Cholesteryl ester transfer protein catalyzes the transfer of cholesteryl esters from high-density lipoprotein (HDL) donors to apolipoprotein B-containing lipoprotein acceptors.

Methods: The CETP concentration, lipid profiles, and the rate of cholesteryl ester transfer (CET) from a tracer dose of radiolabeled HDL toward endogenous lipoproteins were determined within 24 h after symptom onset.

Results: Among 347 patients with first MI, CETP concentration, triglycerides, and non–HDL-cholesterol increased across tertiles of the CET rate, whereas HDL-cholesterol, HDL, and LDL sizes decreased gradually. Among lipoprotein donors and acceptors, the best predictors of the CET rate were HDL2b and non–HDL-cholesterol, respectively. Mean age at first MI was 8.5 years lower in the patients from the highest CET tertile than in those in the lowest CET tertile. Diagonal stratification according to both non–HDL-cholesterol and HDL2b tertiles revealed that patients in the highest CET group were 18 years younger than patients in the lowest CET group. Parameters of the high CETP mass/high non–HDL-cholesterol/low HDL2b triad were independently associated with the CET rate.

Conclusions: In patients with acute MI, high CET rates are characterized by the presence of the high CETP mass/high non–HDL-cholesterol/low HDL2b triad. The association of high CET rates with young age at first MI lends support to a significant contribution of CETP to the accelerated progression of disease among asymptomatic patients.

Abbreviations and Acronyms
  apoB = apoliprotein B
  BMI = body mass index
  CET = cholesteryl ester transfer
  CETP = cholesteryl ester transfer protein
  CHD = coronary heart disease
  HDL = high-density lipoprotein
  ICD = International Classification of Diseases
  LDL = low-density lipoprotein
  MI = myocardial infarction
  VLDL = very-low-density lipoproteins


Related Article

Is the Cholesteryl Ester Transfer Protein Proatherogenic or Antiatherogenic in Humans?
Marina Cuchel and Daniel J. Rader
J. Am. Coll. Cardiol. 2007 50: 1956-1958. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Lipid Res.Home page
P. Wiesner, K. Leidl, A. Boettcher, G. Schmitz, and G. Liebisch
Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
J. Lipid Res., March 1, 2009; 50(3): 574 - 585.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Movva and D. J. Rader
Laboratory Assessment of HDL Heterogeneity and Function
Clin. Chem., May 1, 2008; 54(5): 788 - 800.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Cuchel and D. J. Rader
Is the Cholesteryl Ester Transfer Protein Proatherogenic or Antiatherogenic in Humans?
J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1956 - 1958.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement